Nevertheless, since we have also found that IFN-β can restrict the propagation of ZIKV and enhance the survival of NSCs, the administration of IFN may provide a treatment strategy to protect NSCs from infections by neurotropic viruses. The gene discussed is IFNB1; the disease is infection.